联康生物科技集团有限公司（股票代码：00690）于2026年5月4日发布2026年4月（截至4月30日）证券变动月报表。公告显示，公司本月已发行股份数量为5,971,228,147股，库藏股份数量为0股，与上月末保持一致。法定股本和注册股本同样无变化，分别维持在500,000,000,000股（每股面值0.01港元）和总额50亿港元。
根据月报，公司当月并无新增发行、回购或注销股份行为，股本结构保持不变。另据公告披露，联康生物科技集团于报告期内共拥有9批次2016年股份期权计划，对应期权数量合计420,589,000股。截至4月底，相关股份期权数量及其行使情况均未发生变化，本月无新增股份发行或期权行权记录。
公告显示，公司已确认保持充足的公众持股量，并持续遵守香港联交所《上市规则》及相关法律法规的要求。据悉，本次公告由公司秘书何詠欣女士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.